Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer.
about
Expression of multidrug resistance proteins in invasive ductal carcinoma of the breastMolecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.Multiplication of Chromosome 17 Centromere Is Associated with Prognosis in Patients with Invasive Breast Cancers Exhibiting Normal HER2 and TOP2A Status.Pharmacogenetics of genes across the doxorubicin pathway.Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets.
P2860
Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Topo2α protein expression pred ...... dvanced primary breast cancer.
@ast
Topo2α protein expression pred ...... dvanced primary breast cancer.
@en
Topo2α protein expression pred ...... dvanced primary breast cancer.
@nl
type
label
Topo2α protein expression pred ...... dvanced primary breast cancer.
@ast
Topo2α protein expression pred ...... dvanced primary breast cancer.
@en
Topo2α protein expression pred ...... dvanced primary breast cancer.
@nl
prefLabel
Topo2α protein expression pred ...... dvanced primary breast cancer.
@ast
Topo2α protein expression pred ...... dvanced primary breast cancer.
@en
Topo2α protein expression pred ...... dvanced primary breast cancer.
@nl
P2093
P2860
P50
P356
P1476
Topo2α protein expression pred ...... dvanced primary breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605960
P407
P577
2010-11-09T00:00:00Z
P5875
P6179
1048641448